Observational study on advanced chronic liver diseases in Vienna
VICIS - Vienna Cirrhosis Study
This study looks at patients with advanced chronic liver diseases in Vienna to see how their condition affects blood pressure in the liver and to collect samples for future research.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Medical University of Vienna Academic / other |
| Locations | 1 site (Vienna) |
| Trial ID | NCT03267615 on ClinicalTrials.gov |
What this trial studies
The VICIS study involves patients with advanced chronic liver diseases treated at the Vienna General Hospital. Participants will undergo regular follow-ups and clinical visits, during which clinical and laboratory parameters will be recorded. The study aims to assess the degree of portal hypertension and other related conditions through various diagnostic methods, including HVPG measurement and liver stiffness assessment. Additionally, a biobank will be established to collect biological samples from participants for further research.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 100 with advanced chronic liver disease as indicated by specific clinical criteria.
Not a fit: Patients who do not have advanced chronic liver disease or those who withdraw consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and management of advanced chronic liver diseases, potentially leading to improved patient outcomes.
How similar studies have performed: Other studies focusing on advanced chronic liver diseases have shown promise in improving patient management, making this approach relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \>18 years and \<100 years * Diagnosis of advanced chronic liver disease (by liver stiffness ≥10kPa, HVPG\>5mmHg or Histology F3/F4) * Written informed consent Exclusion Criteria: * Withdrawal of written informed consent
Where this trial is running
Vienna
- Medical University of Vienna — Vienna, Austria (Recruiting)
Study contacts
- Principal investigator: Thomas Reiberger, M.D. — Medical University of Vienna
- Study coordinator: Thomas Reiberger, M.D.
- Email: thomas.reiberger@meduniwien.ac.at
- Phone: +43140400
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.